Article
ERβ regulates NSCLC phenotypes by controlling oncogenic RAS signaling.
Molecular cancer research : MCR - 1 Jun 2014
Nikolos Fotis, Thomas Christoforos, Rajapaksa Gayani, Bado Igor, Gustafsson Jan-Åke
Abstract excerpt
UNLABELLED: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. In addition to the aberrant growth factor signaling, dysregulation of other pathways, such as those mediated by estrogens and their receptors, has been linked to NSCLC initiation and progression. Although the expression of wild-type estrogen receptor β (ERβ1) has been associated with prolonged disease-free...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
